HAEMONETICS CORP — Director's Dealing 2010

Sep 14, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2010-09-10

Reporting Person: ALLEN PETER M (Chief Marketing Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-09-10	Common Stock	S	1866	$54.8318	Disposed	5999	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-09-10	Non-Qualified Stock Option (right to buy)	$21.46	M	1866	Disposed	2013-09-03	Common Stock (1866)	Direct

Footnotes

F1: Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.